Both peptides show strong preclinical evidence for tendon healing, but through different mechanisms
Novo Nordisk submitted an NDA (new drug application) to the FDA on December 18, 2025, which is the formal step companies take when seeking approval for a medication to be marketed for public use
Semaglutide is taken as a subcutaneous (under the skin) injection once a week
Food Demand in a Post-Ozempic World. CHOICES Magazine
Vomiting : Some users experience vomiting, which is usually temporary and may subside with continued use
It helps in weight loss through several mechanisms such as appetite regulation, insulin sensitivity improvement, blood sugar level regulation, slowed gastric emptying, increased fat oxidation, energy expenditure enhancement, and hormonal balance modulation